Spectral Medical Future Growth
Future criteria checks 1/6
Spectral Medical is forecast to grow revenue at 14.3% per annum. EPS is expected to grow by 71.8% per annum.
Key information
n/a
Earnings growth rate
71.8%
EPS growth rate
| Biotechs earnings growth | 42.7% |
| Revenue growth rate | 14.3% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 11 Nov 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2025 | 2 | N/A | N/A | N/A | 1 |
| 12/31/2024 | 2 | N/A | N/A | N/A | 1 |
| 9/30/2024 | 2 | -25 | -9 | -9 | N/A |
| 6/30/2024 | 2 | -19 | -9 | -9 | N/A |
| 3/31/2024 | 2 | -19 | -9 | -8 | N/A |
| 12/31/2023 | 2 | -16 | -11 | -11 | N/A |
| 9/30/2023 | 2 | -10 | -11 | -11 | N/A |
| 6/30/2023 | 2 | -9 | -10 | -10 | N/A |
| 3/31/2023 | 2 | -7 | -11 | -11 | N/A |
| 12/31/2022 | 2 | -8 | -10 | -10 | N/A |
| 9/30/2022 | 2 | -7 | -10 | -10 | N/A |
| 6/30/2022 | 1 | -7 | -10 | -10 | N/A |
| 3/31/2022 | 2 | -7 | -10 | -9 | N/A |
| 12/31/2021 | 2 | -7 | -9 | -9 | N/A |
| 9/30/2021 | 2 | -8 | -9 | -8 | N/A |
| 6/30/2021 | 2 | -8 | -9 | -8 | N/A |
| 3/31/2021 | 2 | -7 | -8 | -7 | N/A |
| 12/31/2020 | 2 | -9 | -1 | 0 | N/A |
| 9/30/2020 | 2 | -8 | -1 | 0 | N/A |
| 6/30/2020 | 2 | -8 | 1 | 1 | N/A |
| 3/31/2020 | 3 | -7 | 2 | 2 | N/A |
| 12/31/2019 | 3 | -5 | -3 | -3 | N/A |
| 9/30/2019 | 4 | -3 | -2 | -2 | N/A |
| 6/30/2019 | 4 | -2 | -2 | -1 | N/A |
| 3/31/2019 | 3 | -3 | -2 | -2 | N/A |
| 12/31/2018 | 4 | -2 | -2 | -2 | N/A |
| 9/30/2018 | 3 | -4 | -3 | -3 | N/A |
| 6/30/2018 | 3 | -4 | N/A | -3 | N/A |
| 3/31/2018 | 4 | -4 | N/A | -3 | N/A |
| 12/31/2017 | 4 | -4 | N/A | -4 | N/A |
| 9/30/2017 | 4 | -4 | N/A | -5 | N/A |
| 6/30/2017 | 4 | -6 | N/A | -7 | N/A |
| 3/31/2017 | 3 | -8 | N/A | -9 | N/A |
| 12/31/2016 | 4 | -10 | N/A | -11 | N/A |
| 9/30/2016 | 3 | -11 | N/A | -11 | N/A |
| 6/30/2016 | 3 | -11 | N/A | -10 | N/A |
| 3/31/2016 | 3 | -10 | N/A | -9 | N/A |
| 12/31/2015 | 3 | -10 | N/A | -9 | N/A |
| 9/30/2015 | 3 | -10 | N/A | -9 | N/A |
| 6/30/2015 | 3 | -9 | N/A | -9 | N/A |
| 3/31/2015 | 3 | -9 | N/A | -9 | N/A |
| 12/31/2014 | 3 | -9 | N/A | -10 | N/A |
| 9/30/2014 | 3 | -11 | N/A | -11 | N/A |
| 6/30/2014 | 3 | -12 | N/A | -10 | N/A |
| 3/31/2014 | 3 | -12 | N/A | -10 | N/A |
| 12/31/2013 | 3 | -11 | N/A | -9 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: Insufficient data to determine if SD4's forecast earnings growth is above the savings rate (1%).
Earnings vs Market: Insufficient data to determine if SD4's earnings are forecast to grow faster than the German market
High Growth Earnings: Insufficient data to determine if SD4's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: SD4's revenue (14.3% per year) is forecast to grow faster than the German market (5.6% per year).
High Growth Revenue: SD4's revenue (14.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SD4's Return on Equity is forecast to be high in 3 years time